Cargando…

Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells

BACKGROUND: Glucagon-like peptide 1 (GLP-1), an incretin hormone well known for its glucose-lowering effect, was recently reported to exert an anabolic effect on bone. Although the exact mechanism is not known, it likely involves the GLP-1 receptor (GLP-1R), which is expressed in some osteoblastic c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Yun Kyung, Bae, Min Jung, Kim, Ju In, Kim, Joo Hyoung, Choi, Soo Jong, Kwon, Su Kyoung, An, Joon Hyop, Kim, Sang Soo, Kim, Bo Hyun, Kim, Yong Ki, Kim, In Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285026/ https://www.ncbi.nlm.nih.gov/pubmed/25325271 http://dx.doi.org/10.3803/EnM.2014.29.4.567

Ejemplares similares

Pentraxin-3 Modulates Osteogenic/Odontogenic Differentiation and Migration of Human Dental Pulp Stem Cells
por: Kim, Yeon, et al.
Publicado: (2019)

Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes
por: Lee, Hye Min, et al.
Publicado: (2015)

Inhibition of Gastrin-Releasing Peptide Attenuates Phosphate-Induced Vascular Calcification
por: Park, Hyun-Joo, et al.
Publicado: (2020)

Involvement of Gastrin-Releasing Peptide Receptor in the Regulation of Adipocyte Differentiation in 3T3-L1 Cells
por: Kim, Mi-Kyoung, et al.
Publicado: (2018)

Gastrin-releasing peptide promotes the migration of vascular smooth muscle cells through upregulation of matrix metalloproteinase-2 and -9
por: Park, Hyun-Joo, et al.
Publicado: (2017)

Effects of Glucagon-Like Peptide-1 Analogue and Fibroblast Growth Factor 21 Combination on the Atherosclerosis-Related Process in a Type 2 Diabetes Mouse Model
por: Kim, Jin Hee, et al.
Publicado: (2021)

Polymer-Based Delivery of Glucagon-Like Peptide-1 for the Treatment of Diabetes
por: Kim, Pyung-Hwan, et al.
Publicado: (2012)

Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus
por: Bae, Jae Hyun, et al.
Publicado: (2020)

Effects of glucagon‐like peptide‐1 receptor agonists on kidney function and safety in type 2 diabetes patients
por: Kim, Min Kyung, et al.
Publicado: (2021)

Medicinal Plants Qua Glucagon-Like Peptide-1 Secretagogue via Intestinal Nutrient Sensors
por: Kim, Ki-Suk, et al.
Publicado: (2015)

Neuromedin B modulates phosphate-induced vascular calcification
por: Park, Hyun-Joo, et al.
Publicado: (2021)

Inhibition of the Semaphorin 4D-Plexin-B1 axis prevents calcification in vascular smooth muscle cells
por: Park, Hyun-Joo, et al.
Publicado: (2023)

Glucagon peptide-like 1 receptor (GLP-1R) expression per se: a new insight into neurodegenerative disease?
por: Kim, Dong-il, et al.
Publicado: (2015)

Adiposity in the Relationship between Serum Vitamin D Level and Insulin Resistance in Middle-Aged and Elderly Korean Adults: The Korea National Health and Nutrition Examination Survey 2008
por: Kang, Ji Hyun, et al.
Publicado: (2013)

Pro-Angiogenic and Osteogenic Effects of Adipose Tissue-Derived Pericytes Synergistically Enhanced by Nel-like Protein-1
por: An, Hyun-Ju, et al.
Publicado: (2021)

Glucagon-like peptide-1 analog liraglutide leads to multiple metabolic alterations in diet-induced obese mice
por: Park, Seokjae, et al.
Publicado: (2022)

Renal Tubular Glucagon-Like Peptide-1 Receptor Expression Is Increased in Early Sepsis but Reduced in Chronic Kidney Disease and Sepsis-Induced Kidney Injury
por: Choi, Jae Hyun, et al.
Publicado: (2019)

Evaluation of Adiposity-Related Biomarkers as Metabolic Syndrome Indicators
por: Bae, Yun-Jung, et al.
Publicado: (2013)

The aglycone of ginsenoside Rg3 enables glucagon-like peptide-1 secretion in enteroendocrine cells and alleviates hyperglycemia in type 2 diabetic mice
por: Kim, Ki-Suk, et al.
Publicado: (2015)

Infection of Porphyromonas gingivalis Increases Phosphate-Induced Calcification of Vascular Smooth Muscle Cells
por: Park, Hyun-Joo, et al.
Publicado: (2020)

Cryopreservation of lipoaspirates: in vitro measurement of the viability of adipose‐derived stem cell and lipid peroxidation
por: Kim, Dong Yeon, et al.
Publicado: (2020)

Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes
por: Jeon, Yun Kyung, et al.
Publicado: (2011)

Prevalence of BRAF(V600E) Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAF(V600E) Prevalent Area
por: Kim, Hyereen, et al.
Publicado: (2018)

Urinary Cystatin C and Tubular Proteinuria Predict Progression of Diabetic Nephropathy
por: Kim, Sang Soo, et al.
Publicado: (2013)

Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors
por: Yi, Wook, et al.
Publicado: (2022)

Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function
por: Kim, Young-Kook, et al.
Publicado: (2020)

Hispidulin Inhibits the Vascular Inflammation Triggered by Porphyromonas gingivalis Lipopolysaccharide
por: Kim, Yeon, et al.
Publicado: (2023)

Hypoxia Regulates the Expression of the Neuromedin B Receptor through a Mechanism Dependent on Hypoxia-Inducible Factor-1α
por: Park, Hyun-Joo, et al.
Publicado: (2013)

ID1-Mediated BMP Signaling Pathway Potentiates Glucagon-Like Peptide-1 Secretion in Response to Nutrient Replenishment
por: Jeong, Jae Woong, et al.
Publicado: (2020)

Author Correction: Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors
por: Yi, Wook, et al.
Publicado: (2023)

Ghrelin and glucagon-like peptide-1 according to body adiposity and glucose homeostasis
por: Lopes, Karynne Grutter, et al.
Publicado: (2023)

Insulin and glucagon levels of umbilical cord blood in appropriate for gestational age - preterm infants with or without postnatal hypoglycemia
por: Park, Jae Hyun, et al.
Publicado: (2016)

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
por: Kim, Hyun Jin, et al.
Publicado: (2017)

Postprandial Glucose, Insulin, and Glucagon-Like Peptide-1 Responses in Healthy Adults after Consumption of Chocolate-Products
por: Choi, Yunjung, et al.
Publicado: (2020)

Expression dynamics of integrin α2, α3, and αV upon osteogenic differentiation of human mesenchymal stem cells
por: Lee, Hyun Min, et al.
Publicado: (2020)

Asthma Exacerbations and Glucagon-Like Peptide-1 Receptor Agonists: a Review of the Current Evidence
por: Kaplan, Alan G., et al.
Publicado: (2022)

Effects of Egg Yolk-Derived Peptide on Osteogenic Gene Expression and MAPK Activation
por: Kim, Hye Kyung, et al.
Publicado: (2014)

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea
por: Oh, Seungjoon, et al.
Publicado: (2015)

Involvement of Heme Oxygenase-1 in Orexin-A-induced Angiogenesis in Vascular Endothelial Cells
por: Kim, Mi-Kyoung, et al.
Publicado: (2015)

Activation of intestinal olfactory receptor stimulates glucagon-like peptide-1 secretion in enteroendocrine cells and attenuates hyperglycemia in type 2 diabetic mice
por: Kim, Ki-Suk, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f8qbsr4u1gbck31tjmch7jap26